Illumina Buys Maker Of Down Syndrome Test For $350M
January 7, 2013 - 12:15pm
Illumina, Inc. (NASDAQ:ILMN), the leading manufacturer of DNA sequencing machines, said on Monday that it will buy Verinata Health for about $350m in cash.
The move is intended to spearhead Illumina’s push into the diagnostics business.
…The privately held VerinataThe post Illumina Buys Maker Of Down Syndrome Test For $350M appeared first on ValueWalk.
Continue reading this article »
Share This Article: